Eu hta regulation and joint clinical assessment—threat or opportunity?

HIGHLIGHTS

• What: The aim of this Article is to take a closer look at the new EU HTA regulation and analyze threats and opportunities for manufacturers and what the resulting opportunities and threats will be at the affiliate level throughout the EU.
• Who: Volker Schuster from the what the resulting opportunities and threats will be at the affiliate level throughout the EU have published the research: EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?, in the Journal: (JOURNAL)

SUMMARY

All other aspects of the HTA process, especially the economic evaluation . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.